Over 130 million doses of coronavirus vaccines have been administered in the United States since vaccination efforts first began in December 2020, with over a million vaccines now being given every day. Because of the vaccine rollout’s fast pace, the US has one of the highest rates of doses administered in the world.
Americans are evidently satisfied with this accomplishment: the latest poll conducted by Redfield & Wilton Strategies finds a large majority (71%) of Americans are satisfied with the United States’ vaccination program so far, whereas 29% are not satisfied. At the state level, respondents are slightly less but still widely satisfied with their state’s vaccination program (66% are satisfied and 34% are not satisfied).
Satisfaction with the vaccination programs at both the federal and state level is high across age groups. Likewise, significant majorities of both 2020 Donald Trump and Joe Biden voters are satisfied with the national and state vaccination programs. That being said, a greater proportion of Biden voters are satisfied with the national (80%) and their state (74%) vaccination programs when compared to Trump voters’ satisfaction with the national (63%) and their state (60%) vaccination programs, suggesting a degree of partisan division on the topic.
Americans seem to be much more satisfied with their nation’s vaccination efforts than Continental Europeans are, while also having lower levels of vaccine scepticism. Among American respondents who have not received a coronavirus vaccine, about half (52%) intend to get vaccinated if a vaccine becomes available to them at little to no financial cost within the next year. Meanwhile, a third (33%) of respondents said they would not get themselves vaccinated, while 15% don’t know.
There also appears to be a partisan divide among those who intend to get vaccinated: 47% of 2020 Trump voters who have not received a vaccine said they will not get themselves vaccinated, while 76% of Biden voters said they will get themselves vaccinated.
Overall, among respondents who plan to get themselves vaccinated, 61% said it does not matter which specific coronavirus vaccine they receive, as along as it has been approved for use in the United States. The specific vaccine does matter, however, for 39% of respondents.
Indeed, a majority of respondents said they would feel safe taking the three vaccines currently authorized for use in the United States: Moderna (64%), Pfizer-BioNTech (63%), and Johnson & Johnson (61%). Conversely, a plurality of respondents said they would feel unsafe taking China’s SinoVac (45%) and Russia’s Sputnik V (46%) vaccines. Meanwhile, following global confusion about the efficacy and possible side effects of the Oxford-AstraZeneca vaccine, Americans are split on whether they would feel safe (32%) or unsafe (32%) taking the Oxford-AstraZeneca vaccine, while 35% said they don’t know.
With President Biden currently promising a vaccine for every adult by mid-May and the possibility of vaccine surpluses looming, some have called upon the United States to distribute its vaccine supply to other countries. Indeed, the United States recently sent five million doses of the Oxford-AstraZeneca vaccine to Canada and Mexico, as that particular vaccine has not been authorized for use in the US. Our latest poll finds 57% of respondents agreeing that the US should assist other nations’ vaccination efforts.
In particular, a substantial majority (72%) of Joe Biden voters believe the US should assist other countries’ vaccination efforts, whereas fewer—but still a plurality—of Donald Trump voters hold this view (43%).
Just 15% of respondents disagree that the US should assist other nations’ vaccination efforts, including 25% of 55-to-64-year-olds.
The vaccination programme currently underway in the United States has been historic in its scale, and, given its success, the majority of Americans—Trump and Biden voters alike—are satisfied with it. Most Americans plan to get vaccinated, if they have not been already, and most would feel safe getting any of the three vaccines that have been authorized in the United States. It remains to be seen whether the United States will shift its focus to other countries’ vaccination efforts once its own have concluded, though it is clear that such a move would be met with considerable support from Americans.